Aug 24, 2015
The panel is Part III of MassBio’s Forum Series: The New Biopharma BD Landscape—All You Need to Know to Survive & Thrive. Hear Jay Mohr moderate on Tuesday, September 22nd at 8:00 a.m. Click here for the link.
Jul 23, 2015
Questions that Cause Biotech CEOs to Lose Sleep: Should I divert funds to the new and promising program or stay focused? Does my team have the skills to take us to the next level? Is our board the right board for the company we want to be? How can I get the best...
Jun 25, 2012
The Locust Walk team is proud to share with you today’s news of our client, Otsuka’s, worldwide agreement to develop novel sensor-based drugs with Proteus Digital Health, Inc.
May 10, 2012
The Locust Walk team is proud to share with you today’s news of our client, InterMune’s, divestiture of Actimmune® (interferon gamma-1b) to Vidara Therapeutics.
Dec 8, 2011
Locust Walk announced today the formation of a related broker / dealer, Locust Walk Securities, LLC (LWS). Augmenting Locust Walk’s business and corporate development execution, strategic planning and commercial assessments for life science companies, LWS will...
